1. Incidence and risk factors for secondary pulmonary infections in patients hospitalized with coronavirus disease 2019 pneumonia
- Author
-
Ali Hani Al-Tarbsheh, Megan Keenan, Scott Beegle, Jeannette Mullins, Anupama Tiwari, Amit Chopra, Paul J. Feustel, Sana Ghalib, Esha Jain, Hau Chieng, and Woon H. Chong
- Subjects
Adult ,medicine.medical_specialty ,secondary pulmonary infections ,Coronavirus disease 2019 (COVID-19) ,secondary bacterial infections ,Lymphocyte ,030204 cardiovascular system & hematology ,Article ,Procalcitonin ,coronavirus disease 2019 ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Retrospective Studies ,Coinfection ,SARS-CoV-2 ,business.industry ,Incidence ,Incidence (epidemiology) ,COVID-19 ,General Medicine ,Odds ratio ,bacterial infections and mycoses ,medicine.disease ,Hospitalization ,Pneumonia ,medicine.anatomical_structure ,business ,Nadir (topography) ,severe acute respiratory syndrome coronavirus 2 ,Respiratory tract - Abstract
Background Secondary pulmonary infections (SPI) have not been well described in COVID-19 patients. Our study aims to examine the incidence and risk factors of SPI in hospitalized COVID-19 patients with pneumonia. Methods This was a retrospective, single-center study of adult COVID-19 patients with radiographic evidence of pneumonia admitted to a regional tertiary care hospital. SPI was defined as microorganisms identified on the respiratory tract with or without concurrent positive blood culture results for the same microorganism obtained at least 48 hours after admission. Results Thirteen out of 244 (5%) had developed SPI during hospitalization. The median of the nadir lymphocyte count during hospitalization was significantly lower in patients with SPI as compared to those without SPI [0.4 K/uL (IQR 0.3-0.5) versus 0.6 K/uL (IQR 0.3-0.9)]. Patients with lower nadir lymphocyte had an increased risk of developing SPI with odds ratio (OR) of 1.21 (95% CI: 1.00 to 1.47, p=0.04) per 0.1 K/uL decrement in nadir lymphocyte. The baseline median inflammatory markers of CRP [166.4 mg/L vs. 100.0 mg/L, p=0.01] and D-dimer (18.5 mg/L vs. 1.4 mg/L, p
- Published
- 2022